Dr. Heyman, most recently served as Chairman of Vividion Therapeutics, which was purchased in August 2021 by Bayer Pharmaceuticals. He is the co-founder and Chairman of both ORIC Pharmaceuticals, which is developing drugs to overcome resistance in cancer, and Metacrine Inc., developing therapeutics for liver and gastrointestinal diseases. Previously, Dr. Heyman was the co-founder and CEO of Aragon and Seragon Pharmaceuticals, which is focused on therapeutics targeting hormone dependent cancers. J&J purchased Aragon in 2013 and Genentech purchased Seragon in 2014. He is the author and inventor of more than 125 publications and patents.